Novartis Survey
![Novartis Survey Challenges Perception of CML as a Resolved Disease, Revealing Ongoing Impact and Need for Attention](https://pharmtales.com/wp-content/uploads/2023/06/Novartis-Survey-Challenges-Perception-of-CML-as-a-Resolved-Disease-Revealing-Ongoing-Impact-and-Need-for-Attention.jpg)
Novartis Survey Challenges Perception of CML as a Resolved Disease, Revealing Ongoing Impact and Need for Attention
SG Tylor
Source: Novartis On June 9, 2023, Novartis reveals CML (chronic myeloid leukemia) SUN Results at 2023 European Hematology Association (EHA) ...